“Singapore’s Export Slump: 4.6% Drop in July – What This Means for the Economy & Markets” Singapore’s non‑oil domestic exports (NODX) plunged 4.6% year-on-year in July 2025, well below expectations of a 1.8% contraction . The sharp decline was driven largely by a staggering 93.5% collapse in pharmaceutical exports to the U.S. and a substantial drop in petrochemicals, food preparations, and other non-electronic goods . Key insights: • Exports to the U.S. plunged 42.7%, signalling weaker demand and possibly the onset of U.S. tariff impacts . • By contrast, electronics shipments—led by PCs (+80.4%), integrated circuits (+8%), and PCBs (+25.8%)—provided a rare bright spot . • Trade with the EU, Taiwan, South Korea, and Hong Kong actually strengthened, suggesting shifting regional demand patterns . Implications: • Economic growth: Despite the July slump, the Singapore government raised its 2025 GDP forecast to 1.5%–2.5%, up from 0%–2%, buoyed by better-than-expected performance in the first half . Still, authorities caution that growth may slow in the second half as export frontloading fades . • Market sentiment: The drop in pharmaceutical exports and weak U.S. demand could put pressure on stock indices, particularly in sectors linked to chemicals, healthcare, and trade-exposed industries. However, strength in electronics may help cushion investor sentiment. • Policy and global trade outlook: Singapore’s leadership, including Prime Minister Lawrence Wong, warns of potential escalation in U.S. trade barriers—especially toward pharmaceuticals and semiconductors—even under the existing 10% baseline tariff . Enterprise Singapore remains cautious, projecting 1%–3% NODX growth for the year but anticipates softness ahead . ⸻ Hashtag #SingaporeExportSlump...